Nuria Godessart
Almirall R&D
Barcelona, CT, Spain
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Characterisation and Profiling of Standard Atopic Dermatitis Therapies in a Chronic Dermatitis Murine Model Induced by Oxazolone.
Journal: Experimental dermatology
Published: April 15, 2024
Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment of recessive dystrophic epidermolysis bullosa.
Journal: Scientific reports
Published: March 04, 2024
β2-adrenoreceptors control human skin microvascular reactivity.
Journal: European journal of dermatology : EJD
Published: July 26, 2021
Prediction of the skin permeability of topical drugs using in silico and in vitro models.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: February 07, 2019
Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita.
Journal: Frontiers in immunology
Published: November 29, 2017
Characterization of the chloroquine-induced mouse model of pruritus using an automated behavioural system.
Journal: Experimental dermatology
Published: June 06, 2017
Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis.
Journal: Neuroscience letters
Published: November 27, 2012
Discovery of a novel class of zwitterionic, potent, selective and orally active S1P₁ direct agonists.
Journal: Bioorganic & medicinal chemistry letters
Published: May 25, 2012
Profiling of dihydroorotate dehydrogenase, p38 and JAK inhibitors in the rat adjuvant-induced arthritis model: a translational study.
Journal: British journal of pharmacology
Published: January 11, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026